Nursing care for Guillain-Barré syndrome. Systematic review [Cuidado de enfermería en el Síndrome de Guillain Barré. Revisión sistemática]
DOI:
https://doi.org/10.62574/8h9a5s91Keywords:
Guillain-Barre Syndrome, nervous system diseases, demyelinating diseasesAbstract
Objective: to analyze the integral nursing care of patients with fibrous dysplasia of bone. Method: Systematic review. Results and conclusion: The results highlight the essential role of nursing in the management of this condition, encompassing not only the control of physical symptoms, such as pain and functional limitations, but also the education of the patient and their family, emotional support and coordination with the interdisciplinary team.
Downloads
References
Zubair AS, Bae JY, Desai K. Facial Diplegia Variant of Guillain-Barré Syndrome in Pregnancy Following COVID-19 Vaccination: A Case Report. Cureus. 2022;14(2):e22341. Published 2022 Feb 17. doi:10.7759/cureus.22341
Shaheen N, Ramadan A, Nashwan AJ, et al. Guillain-Barré syndrome following COVID-19 vaccination: An updated systematic review of cases. Clin Case Rep. 2023;11(6):e7456. Published 2023 Jun 7. doi:10.1002/ccr3.7456
Busl KM, Fried H, Muehlschlegel S, et al. Guidelines for Neuroprognostication in Adults with Guillain-Barré Syndrome [published correction appears in Neurocrit Care. 2023 Apr 26;:] [published correction appears in Neurocrit Care. 2023 Dec;39(3):752]. Neurocrit Care. 2023;38(3):564-583. doi:10.1007/s12028-023-01707-3
Haldeman D, Zulkosky K. Treatment and nursing care for a patient with Guillain-Barré syndrome. Dimens Crit Care Nurs. 2005;24(6):267-272. doi:10.1097/00003465-200511000-00004
Sheikh AB, Chourasia PK, Javed N, et al. Association of Guillain-Barre syndrome with COVID-19 infection: An updated systematic review. J Neuroimmunol. 2021;355:577577. doi:10.1016/j.jneuroim.2021.577577
Kushner DS, Johnson-Greene D, Felix ER, Miller C, Cordero MK, Thomashaw SA. Predictors of discharge to home/community following inpatient-rehabilitation in a US national sample of Guillain-Barre-Syndrome patients. PLoS One. 2023;18(5):e0286296. Published 2023 May 25. doi:10.1371/journal.pone.0286296
Hu K, Liu W, Gan Y, Huang Z. Transcriptome analysis of childhood Guillain-Barré syndrome associated with supportive care. Front Pediatr. 2022;10:1008996. Published 2022 Sep 26. doi:10.3389/fped.2022.1008996
Yakoby J, Litvak I, Yu E. Guillain-Barré Syndrome after Novel Coronavirus Disease 2019. J Emerg Med. 2021;61(4):e67-e70. doi:10.1016/j.jemermed.2021.03.022
Santos YD. Reporte de caso; síndrome de Guillain-barré, manejo multidisciplinario en un hospital de segundo nivel [Case report; Guillain-barré syndrome, multidisciplinary management in a second level hospital]. RSM [Internet]. 2021;75(4).
Pacheco M, Chagua, A; Segura, D; Alvares, K; Aquino F. Síndrome de Guillain-Barré fulminante imitando muerte encefálica: reporte de caso [Fulminant Guillain-Barré syndrome mimicking encephalic death: Case report]. Neurología Argentina. 2022; 14: p. 67-70.
López-Hernández JC, Galnares-Olalde JA, Gutiérrez A, Estrada SA, García-Grimshaw M, Vargas-Cañas ES. Guillain-Barre syndrome in Mexico: clinical features and validation of Brighton Collaboration Group criteria. Síndrome de Guillain-Barré en México: características clínicas y validación de los criterios de Brighton. Rev Neurol. 2022;74(8):258-264. doi:10.33588/rn.7408.2021437
Miraval-Márquez Fiorella Karina, Vera-Chaupijulca Sharon Mashiel, Sánchez Sanguinetti Martin Diego, Lazo-Velásquez Juan Carlos, Castillo Kohatsu Guillermo, Bujaico-Ascona María Elizabeth et al . Síndrome de Guillain Barré relacionados a infección por SARS - CoV 2 en Lima, Perú. Reporte de casos. Rev Med Hered [Internet]. 2022;33(1): 47-50.
Angarita Diaz Jorge A., Cardenas Sandoval María Paola. Síndrome de Guillain-Barré tras vacunación contra SARS-CoV-2 con Sinovac® [Guillain-Barré syndrome after Sinovac® vaccine for SARS-CoV-2]. Acta Neurol Colomb. [Internet]. 2021; 37(2): 107-108.
Sosa-Hernández O, Sánchez-Cardoza S. Reporte de caso de síndrome de Guillain-Barré posterior a la vacuna COVID BNT162b2 mRNA [Case report of Guillain-Barré Syndrome after COVID BNT162b2 mRNA vaccine]. Vacunas. 2022;23:68-70. doi:10.1016/j.vacun.2022.02.002
Richardson-May J, Purcaru E, Campbell C, Hillier C, Parkin B. Guillain-Barré Syndrome and Unilateral Optic Neuritis Following Vaccination for COVID-19: A Case Report and Literature Review. Neuroophthalmology. 2022;46(6):413-419. Published 2022 May 23. doi:10.1080/01658107.2022.2048861
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Jomahe Nicole Sarmiento-Angulo, María Belén López-Garcés, Kerly Pamela Coba-Gavilanes, Christopher Alexander Analuisa
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
